RIPK3 and Hepatic fibrosis: OGT glycosylates RIPK3 and reduces the stability of the RIPK3 protein and therefore inhibits necroptosis, so that the loss of O-GlcNAc leads to liver fibrosis and inflammation due to unregulated necroptosis [157].